1. Celgene wins FDA approval for drug key to Bristol buyout — FDA approves TAVR valves for low-risk patients — Warning signs always there for the Novartis-AveXis deal — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Recent Activity

Activity stream for all registered members at Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales.

  1. CP Job Ratings posted a new thread.

    ACOR - job rating

    Good benefits. Good manager. Bad price point For current medication. read more... read more ratings or rate your company here

    Forum: Latest CP Job Ratings

    Aug 17, 2019 at 11:02 PM
  2. cafead posted a new thread.

    FDA Approval 'Finally' Recognizes Vertebral Body Tethering as a Mainstream...

    via Zimmer Biomet's first-of-its-kind spinal tether device sets the stage for helping thousands of kids with scoliosis, according to a...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 11:02 PM
  3. cafead posted a new thread.

    Biopharma's biggest sellers – the oldies that just keep giving

    via Enbrel's recent US patent win has ensured a further eight years of exclusivity for the rheumatoid arthritis treatment. Amgen's...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 1:52 PM
  4. cafead posted a new thread.

    Alder BioPharmaceuticals approaches rare status for a Seattle biotech

    via Bothell-based Alder BioPharmaceuticals, Inc. has an opportunity to do something pretty rare in Seattle, if its homegrown migraine...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 1:52 PM
  5. cafead posted a new thread.

    How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals

    via Merck stock jumped Friday after an analyst initiated coverage of the Dow Jones pharma giant with an outperform rating, citing "the...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 1:32 PM
  6. cafead posted a new thread.

    Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

    via The dog days of summer are here and IPO activity has slowed, but that hasn’t stopped some biotech companies from securing a place in...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 1:32 PM
  7. cafead posted a new thread.

    Price, safety will test blockbuster billing for AbbVie's new arthritis drug

    via Doctors caution that the usefulness of a new rheumatoid arthritis drug from AbbVie, while a welcome addition to their tool kits,...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:32 AM
  8. cafead posted a new thread.

    Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi

    via Roche Holding AG has priced its personalized cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of the monthly...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:12 AM
  9. cafead posted a new thread.

    Trump health official: Controversial drug pricing move is 'top priority'

    via A top Trump administration health official on Thursday indicated that the administration is pushing forward with a controversial...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:12 AM
  10. cafead posted a new thread.

    Ahead of FDA decisions on one antibiotic, Nabriva plans resubmission of another

    via As it awaits FDA's decisions on twin NDAs for lefamulin, Nabriva said it plans to resubmit an NDA early next quarter for another one...

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:12 AM
  11. cafead posted a new thread.

    Rinvoq approval bolsters AbbVie's autoimmune portfolio

    via With Humira adalimumab set to face increasing biosimilar competition internationally this year, AbbVie has notched its second U.S....

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:12 AM
  12. cafead posted a new thread.

    Generic Drug Approvals Hit Another Record High as Competition, Quality Questions Linger

    via Another year, another record number of generic drug approvals and tentative approvals for the US Food and Drug Administration (FDA)....

    Forum: Pharma/Biotech Companies - In the News

    Aug 17, 2019 at 12:12 AM
  13. cafead posted a new thread.

    Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

    via The dog days of summer are here and IPO activity has slowed, but that hasn’t stopped some biotech companies from securing a place in...

    Forum: Pharma/Biotech Companies - In the News

    Aug 16, 2019 at 11:52 PM
  14. tinkrbelle replied to the thread NCAA COLLEGE FOOTBALL PICK EM! 2019 Season.

    I’m in!! Thanks for hosting again this year BamaBoy!

    Aug 16, 2019 at 8:11 PM
Loading...